3 Although several factors contributed to this rise in interest, two key developments have been particularly important: Celebrity endorsement: A number of high-profile celebrities, such as Elon Musk, have publicly credited GLP-1RA drugs with their transformative weight loss, leading to a spike in public interest in using the drugs for weight loss
PlexusDx's focus is on optimizing your primary GLP-1/GIP therapy through personalization, not stacking
At Dynasty Clinic, every patient undergoes a full health assessment, hormone baseline testing, and personalised protocol design before beginning peptide therapy
Berberine, a herbal metabolite in the metabolic syndrome: The risk factors, course, and consequences of the disease
Sonn, G
Authors identified 51,408 adults with newly diagnosed type 2 diabetes and overweight or obesity who initiated treatment with either GLP-1 RAs (25,704 users) or SGLT2 inhibitors (25,704 users) following 1:1 propensity score matching to adjust for differences at baseline
